Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joep C Defesche

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Journal of Applied Genetics|February 12, 2008
Clinical course of homozygous familial hypercholesterolemia during childhood: report on 4 unrelated patients with homozygous or compound heterozygous mutations in the LDLR geneJolanta Kubalska, Magdalena Chmara, Janusz Limon, et al.
Journal of Clinical Lipidology|February 24, 2019
The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) studyIlse K Luirink, Marjet J A M Braamskamp, Albert Wiegman, et al.
European Heart Journal|July 3, 2010
A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patientsJorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, et al.
Circulation. Genomic and Precision Medicine|December 19, 2018
A Deep Intronic Variant in LDLR in Familial HypercholesterolemiaLaurens F Reeskamp, Merel L Hartgers, Jorge Peter, et al.
Journal of Hypertension|February 28, 2008
Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemiaJeroen B van der Net, Aaron Isaacs, Geesje M Dallinga-Thie, et al.
Circulation Research|July 19, 2014
Mutations in STAP1 are associated with autosomal dominant hypercholesterolemiaSigrid W Fouchier, Geesje M Dallinga-Thie, Joost C M Meijers, et al.
Atherosclerosis|April 14, 2009
5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemiaDaniëlla M Oosterveer, Jorie Versmissen, Mojgan Yazdanpanah, et al.
Atherosclerosis|January 8, 2011
Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatinArash Alipour, Manuel Castro Cabezas, Jan Willem F Elte, et al.
Clinical Biochemistry|March 26, 2009
Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platformRodrigo Alonso, Joep C Defesche, Diego Tejedor, et al.
Human Mutation|November 19, 2011
Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl LevelsRoeland Huijgen, Barbara Sjouke, Kelly Vis, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Journal of Applied Genetics|February 12, 2008
Clinical course of homozygous familial hypercholesterolemia during childhood: report on 4 unrelated patients with homozygous or compound heterozygous mutations in the LDLR geneJolanta Kubalska, Magdalena Chmara, Janusz Limon, et al.
Journal of Clinical Lipidology|February 24, 2019
The clinical and molecular diversity of homozygous familial hypercholesterolemia in children: Results from the GeneTics of clinical homozygous hypercholesterolemia (GoTCHA) studyIlse K Luirink, Marjet J A M Braamskamp, Albert Wiegman, et al.
European Heart Journal|July 3, 2010
A frequent variant in the ABCA1 gene is associated with increased coronary heart disease risk and a better response to statin treatment in familial hypercholesterolemia patientsJorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, et al.
Circulation. Genomic and Precision Medicine|December 19, 2018
A Deep Intronic Variant in LDLR in Familial HypercholesterolemiaLaurens F Reeskamp, Merel L Hartgers, Jorge Peter, et al.
Journal of Hypertension|February 28, 2008
Haplotype of the angiotensinogen gene is associated with coronary heart disease in familial hypercholesterolemiaJeroen B van der Net, Aaron Isaacs, Geesje M Dallinga-Thie, et al.
Circulation Research|July 19, 2014
Mutations in STAP1 are associated with autosomal dominant hypercholesterolemiaSigrid W Fouchier, Geesje M Dallinga-Thie, Joost C M Meijers, et al.
Atherosclerosis|April 14, 2009
5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemiaDaniëlla M Oosterveer, Jorie Versmissen, Mojgan Yazdanpanah, et al.
Atherosclerosis|January 8, 2011
Mannose binding lectin 2 haplotypes do not affect the progression of coronary atherosclerosis in men with proven coronary artery disease treated with pravastatinArash Alipour, Manuel Castro Cabezas, Jan Willem F Elte, et al.
Clinical Biochemistry|March 26, 2009
Genetic diagnosis of familial hypercholesterolemia using a DNA-array based platformRodrigo Alonso, Joep C Defesche, Diego Tejedor, et al.
Human Mutation|November 19, 2011
Genetic variation in APOB, PCSK9, and ANGPTL3 in carriers of pathogenic autosomal dominant hypercholesterolemic mutations with unexpected low LDL-Cl LevelsRoeland Huijgen, Barbara Sjouke, Kelly Vis, et al.
Pageof 10